Clinical Trial Update: A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase I clinical trial evaluating GC33 in patients with advanced or metastatic hepatocellular carcinoma (liver cancer)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GC33 (codrituzumab)

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Advanced or Metastatic HCC | Phase 1 | Status: COMPLETED